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Reversible heart rhythm 
complexity impairment in patients 
with primary aldosteronism
Yen-Hung Lin1, Vin-Cent Wu1, Men-Tzung Lo2, Xue-Ming Wu3, Chi-Sheng Hung1,  
Kwan-Dun Wu1, Chen Lin2, Yi-Lwun Ho1, Michael Stowasser4 & Chung-Kang Peng5
Excess aldosterone secretion in patients with primary aldosteronism (PA) impairs their cardiovascular 
system. Heart rhythm complexity analysis, derived from heart rate variability (HRV), is a powerful 
tool to quantify the complex regulatory dynamics of human physiology. We prospectively analyzed 
20 patients with aldosterone producing adenoma (APA) that underwent adrenalectomy and 25 
patients with essential hypertension (EH). The heart rate data were analyzed by conventional 
HRV and heart rhythm complexity analysis including detrended fluctuation analysis (DFA) and 
multiscale entropy (MSE). We found APA patients had significantly decreased DFAα2 on DFA 
analysis and decreased area 1–5, area 6–15, and area 6–20 on MSE analysis (all p < 0.05). Area 1–5, 
area 6–15, area 6–20 in the MSE study correlated significantly with log-transformed renin activity 
and log-transformed aldosterone-renin ratio (all p < = 0.01). The conventional HRV parameters 
were comparable between PA and EH patients. After adrenalectomy, all the altered DFA and MSE 
parameters improved significantly (all p < 0.05). The conventional HRV parameters did not change. 
Our result suggested that heart rhythm complexity is impaired in APA patients and this is at least 
partially reversed by adrenalectomy.
Primary aldosteronism (PA) is characterized by an inappropriate production of aldosterone and affects 
5–13% of hypertensive patients1. Recent studies indicate that PA is as the most frequent cause of sec-
ondary hypertension1.
Patients with PA have a higher incidence of cardiovascular events than patients with essential hyper-
tension (EH) matched for hypertension severity2. PA patients also have a higher incidence of altered 
cardiac structure, such as left ventricular hypertrophy and cardiac fibrosis than EH patients, which may 
due to the high plasma aldosterone levels in these patients3. As well as altering cardiac structure, excess 
aldosterone also increases vascular stiffiness4. After removal of aldosterone excess by adrenalectomy or 
blockade of aldosterone action by mineralocorticoid receptor antagonists, the altered structure of the 
cardiovascular system recover4,5.
Aldosterone also influences the autonomic system. In animal studies, infusion of aldosterone into 
cerebral ventricles increases sympathetic nerve activity (SNA) and blood pressure (BP), effects which 
are antagonized by mineralocorticoid antagonist administration6 . In clinical studies, the reported effects 
of aldosterone excess on the autonomic system have been inconsistent. Three muscle SNA studies were 
measured by intraneural microelectrodes in PA patients gave conflicting results7–9.
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Analysis of the variation of heart rate oscillation, mostly known as heart rate variability (HRV), is 
commonly used to assess the alteration of autonomic function in human studies due to its simple, non-
invasive, and inexpensive approach10. Traditional linear analysis of HRV is also used as a tool to evaluate 
the autonomic system, and especially high frequency power spectrum analysis to evaluate parasympa-
thetic function10. HRV has been commonly applied to predict outcome in patients with cardiovascular 
disease11. In recent years, newer methods based on nonlinear and nonstationary signal modeling have 
been developed and successfully applied12. The concept of heart rhythm complexity analysis by nonlin-
ear methods including detrended fractal analysis (DFA) or multiscale entropy (MSE) is based on the 
assumption that a healthy system exhibits a meaningful complex control over different time scales to 
maintain operation in ever-changing environment13,14. Conversely, decreased complexity of heart rate 
dynamics has been demonstrated in patients with diseases states, such as heart failure, stroke, sepsis, and 
critical illness requiring extracorporeal life support15–18. Compared to traditional HRV parameter based 
on linear methodology, heart rhythm complexity analysis showed better predictive power for prognosis 
in patients with cardiovascular disease15,19.
Whether aldosterone excess affects heart rhythm complexity is unclear and formed the basis of the 
current study.
Results
Patients. Twenty patients (9 men) with aldosterone producing adenoma (APA) undergoing adrenal-
ectomy and 25 patients with EH were enrolled. The clinical data are shown in Table 1. Patients with APA 
had significantly higher plasma aldosterone concentration (PAC), higher left ventricular mass index, 
higher plasma aldosterone-to-renin activity ratio (ARR), lower serum potassium levels, and lower plasma 
renin activity (PRA) than patients with EH. Regarding medication usage, a significantly higher percent-
age of APA patients received α -blocker and spironolactone treatment, and lower percentage received 
angiotensin receptor blocker (ARB) treatment.
Holter data. For all (Table 2) linear Holter parameters, there were no differences between the APA 
and EH groups (all p > 0.05). For non-linear parameters, the APA group had significantly higher DFAα 2 
(1.19 ± 0.09 vs. 1.13 ± 0.10, p = 0.046), lower area 1–5 (5.4 ± 1.3 v.s. 6.4 ± 1.0, p = 0.006), lower area 6–15 
(13.4 ± 2.4 vs. 14.9 ± 1.8, p = 0.023) and lower area 6–20 (20.4 ± 3.6 vs. 22.4 ± 2.7, p = 0.036) of the MSE 
parameters than EH group. The entropy over different time scales in APA and EH groups was shown in 
Fig. 1a. The MSE parameters, including area 1–5, area 6–16, and area 6–20 significantly correlated with 
Log PRA and Log ARR (all p < 0.01) (Table 3). Serum potassium levels also significantly correlated with 
area 6–16 and area 6–20 (both p < 0.05).
In multi-variate regression analysis, Log PRA was an independent factor associated with area 6–15 
(β = 0.803, p = 0.007) and area 6–20 (β = 1.158, p = 0.010) in the final models (excluded variables: serum 
potassium levels and Log ARR in both models).
Post-adrenalectomy follow-up. By one year after adrenalectomy, the number of anti-hypertensive 
medications, log PAC, log ARR, and left ventricular mass index had significantly decreased while PRA 
and serum K level had increased (Table 4). Eleven out of 20 patients were cured of hypertension.
Repeat Holter study (Table  5) did not reveal any significant change in linear HRV parameters 
post-operatively. In contrast, DFAα2 decreased significantly (from 1.19 ± 0.09 to 1.13 ± 0.13, p = 0.043). 
The entropy over different time scales in pre- and post-operative APA patients was shown in Fig.  1b. 
Within the MSE parameters, slope 5 (from 0.067 ± 0.055 to 0.098 ± 0.051, p = 0.035), area 1–5 (from 
5.4 ± 1.3 to 6.3 ± 1.1, p = 0.007), area 6–15 (from 13.4 ± 2.4 to 15.5 ± 1.8, p = 0.001), and area 6–20 
(from 20.4 ± 3.6 to 23.4 ± 2.7, p = 0.003) increased significantly.
Discussion
The major findings of this study were 1) APA patients had worse heart rhythm complexity than EH 
patients, and this was independent of BP; 2) In the correlation study regarding all participants, the 
parameters of heart rhythm complexity correlated with Log PRA and Log ARR, but not blood pressure 
or altered cardiac structure; 3) the impaired heart rhythm complexity improved after adrenalectomy.
The presented study is the first study to show the adverse effects of aldosterone on heart rhythm com-
plexity, which quantifies the complex regulatory dynamics of human physiology20. HRV is commonly used 
to assess autonomic function and risk stratification of patients with cardiovascular disease11,21. Compared 
to traditional linear HRV parameters, nonlinear metrics (including DFA and MSE) showed better pre-
dictive power for clinical outcomes in heart failure patients and in an experimental sepsis model15,19,22. 
Recently, the MSE method, specifically developed to treat heterogeneous complexity, was shown to 
extend the traditional entropy algorithm to quantify the information richness over multiple time scales 
in physiological systems20. This complex structure will “break down” in diseased patients, such as those 
with heart failure or with critical illness, and may be further affected in those with poor prognosis15,18. 
In our previous study, MSE provided the best prognostic prediction in patients with heart failure15. 
MSE also predicted outcome of severe traumatic patients requiring intensive care unit admission across 
the diverse spectrum of traumatic injury23, the neurological outcome after stroke16, the clinical conse-
quences of sepsis17, and outcome of patients with critical illness receiving extracorporeal life support18. 
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In the present study, PA patients had worse heart rhythm complexity than EH patients, suggesting that 
aldosterone excess impaired the complex regulatory dynamics of human physiology. Furthermore, there 
were significant associations between heart rhythm complexity and log PRA and log ARR, but not BP 
or cardiac structure in the correlation study regarding all participants. This implied a direct association 
between aldosterone and heart rhythm complexity. Moreover, after adrenalectomy, the impaired heart 
rhythm complexity improved, suggesting that the impairment is at least partially reversible.
In contrast to the significant differences of values in non-linear parameters between PA and EH 
patients, the values of traditional HRV parameters (such as time and frequency domain parameters) 
were comparable in both groups in the current study. This also applied when comparing the pre and 
post-operative data of APA patients. As mentioned earlier, traditional HRV parameters are commonly 
used to evaluate the autonomic system, and particularly high frequency power spectrum analysis to 
evaluate parasympathetic function10. Data from the current study did not provide further evidence to 
support PA patients having worse autonomic function than EH patients.
Patient 
characteristics APA (n = 20)
EH 
(n = 25) P
Age, years 45 ± 9 46 ± 11 0.666
Male sex 9 (45) 11 (44) 0.947
History of 
hypertension, years 5.4 ± 6.6 5.4 ± 4.9 0.982
Body weight, kg 67 ± 13 68 ± 12 0.791
Body height, cm 161 ± 8 164 ± 9 0.270
Creatinine, mg/dL 1.0 ± 0.3 0.9 ± 0.2 0.807
SBP, mmHg 148 ± 13 140 ± 17 0.079
DBP, mmHg 92 ± 11 87 ± 13 0.194
Potassium, mmol/L 3.3 ± 0.8 4.3 ± 0.5 < 0.001
PAC, ng/dL 50 ± 36 31 ± 23 0.029
PRA, ng/mL/hr 0.4 ± 0.5 8.9 ± 11.1 0.001
ARR 1932.8 ± 2797.1 23.6 ± 55.8 0.007
Log PAC 1.6 ± 0.3 1.4 ± 0.2 0.006
Log PRA − 0.9 ± 0.9 0.6 ± 0.7 < 0.001
Log ARR 2.6 ± 0.9 0.9 ± 0.6 < 0.001
LVMI, g/m2 135 ± 38 110 ± 27 0.028
LVEF, % 71 ± 7 73 ± 6 0.488
Adenoma diameter 
on abdominal CT, 
mm
15.5 ± 6.1 — —
Adenoma location 




1.7 ± 0.9 1.8 ± 0.8 0.678
Hypertensive Medication
CCB 13 (65) 15 (60) 0.731
ACEI 0 (0) 2 (8) 0.495
ARB 5 (25) 16 (64) 0.036
Thiazide 3 (15) 1 (4) 0.309
α -blocker 9 (45) 4(16) 0.049
β -blocker 6 (30) 8(32) 0.885
Spironolactone 10 (50) 1 (4) 0.001
Table 1.  Clinical data of patients at baseline. Values are mean ± SD or number (percentage). 
APA = aldosterone producing adenoma; EH = essential hypertension; SBP = systolic blood pressure; 
DBP = diastolic blood pressure; PAC = plasma aldosterone concentration; PRA = plasma renin activity; 
ARR = aldosterone-renin ratio; CCB = calcium channel blocker; ACE-I = angiotensin converting enzyme 
inhibitor; ARB = angiotensin receptor blocker; LVMI = left ventricular mass index; LVEF: left ventricular 
ejection fraction; CT = computed tomography.
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The relation between aldosterone and the autonomic system is complex. In animal studies, excess 
of aldosterone is associated with autonomic dysfunction. It was found that there are mineralocorticoid 
receptors near the hippocampus and regulated by mineralocorticoids and glucocorticoids24. Further, 
aldosterone infusion into cerebral ventricles increased SNA and BP, an effect which was antagonized by 
administration of a mineralocorticoid antagonist6. In another animal model, the increased BP induced 
by aldosterone was blocked by chemical sympathectomy25. In the elderly hypertensive population, the 
mineralocorticoid antagonist spironolactone decreased norepinephrine levels26. The evidence suggests a 
close relationship between aldosterone and the autonomic system.
Whether PA patients have impaired autonomic function is controversial. Acute infusion of aldos-
terone in healthy volunteers increased the standard deviation of RR intervals and total power, and was 
associated with a trend towards increased time domain HRV parameters27. However, in that study, basal 
muscle SNA, BP and heart rate remained unaffected by aldosterone administration. This suggests that, 
acutely, aldosterone infusion tends to increase cardiac vagal activity and has no effect on sympathetic 
activity. PA patients have lower sympathetic vasomotor tone than patients with EH28. Several studies have 
evaluated muscle SNA in patients with PA7,8. In the study by Kontak et al., PA patients had similar mus-
cle SNA to EH patients7. Both PA and EH patients had higher muscle SNA than normotensive subjects. 
However, the muscle SNA decreased significantly after adrenalectomy, accompanied by a decrease in BP7. 
Whether removal of aldosterone excess or decrease of BP contributed to this improvement is unclear. In 
another study by Miyajima et al., PA patients had lower muscle SNA compared to EH patients8. In a third 
study by Matsukawa et al.9, PA patients have lower muscle SNA compared to normotensive subjects. 
Interestingly, the muscle SNA was significantly elevated after unilateral adrenalectomy in PA patients. It 
was in contrast to the study by Kontak et al.7. Although different race and other inter-individual differ-
ences may have contributed to this disparity, it may also reflect the fact that regulation of sympathetic 
activity in PA patients is complex and influenced by factors other than aldosterone itself.
The relationship between aldosterone and parasympathetic activity is also complex and conflicting 
data exist. Acute infusion of aldosterone in healthy volunteers increased cardiac vagal activity in one 
HRV study27. Aliskirin, which reduces activity of the renin-angiotensin-aldosterone system via direct 
inhibition of renin, increased parasympathetic function as measured by two cardiovascular autonomic 
reflex tests29. However, the high frequency domain of HRV, an index of cardiac parasympathetic tone 
did not change29. Studies assessing parasympathetic function in PA are quite few. To the best of our 
knowledge, there are only two studies from the same group dealing with this issue. In the first, the 
baroreflex sensitivity of PA patients was found to be similar to age-matched healthy subjects. In contrast, 
the baroreflex sensitivity was impaired in EH patients30. In the second study from the same group, PA 
APA (n = 20) EH (n = 25) P
Time domain analysis
 Mean, mm 750 ± 102 739 ± 121 0.746
 SDNN, mm 72 ± 18 74 ± 23 0.718
 pNN20, mm 20 ± 16 21 ± 13 0.733
 pNN50, mm 2.8 ± 4.0 3.2 ± 3.8 0.683
Frequency domain analysis
 High frequency 107 ± 115 116 ± 113 0.814
 Low frequency 263 ± 154 314 ± 167 0.297
 LF/HF ratio 4.0 ± 2.3 4.2 ± 2.9 0.799
 Very low frequency 968 ± 376 1018 ± 488 0.711
Detrended fluctuation analysis
 α 1 1.29 ± 0.19 1.26 ± 0.20 0.613
 α 2 1.19 ± 0.09 1.13 ± 0.10 0.046
Multiscale entropy
 Area 1–5 5.4 ± 1.3 6.4 ± 1.0 0.006
 Slope 5 0.067 ± 0.055 0.052 ± 0.058 0.393
 Area 6–15 13.4 ± 2.4 14.9 ± 1.8 0.023
 Area 6–20 20.4 ± 3.6 22.4 ± 2.7 0.036
Table 2.  Holter parameter of patients at baseline. Values are mean ± SD. APA = aldosterone 
producing adenoma; EH = essential hypertension; SDNN = standard deviation of normal RR intervals; 
pNN20 = percentage of the absolute change in consecutive normal RR interval exceeds 20 ms; 
pNN50 = percentage of the absolute change in consecutive normal RR interval exceeds 50 ms; LF/HF = the 
ratio between low and high frequency components.
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patients showed similar high frequency in HRV compared to normotensive subjects, but high frequency 
in HRV was decrease in patients with EH28. These data suggest that, although hypertensive, PA patients 
have intact parasympathetic activity. Against this notion, however, was the observation that the high 
frequency value decreased after adrenalectomy in the PA patients28.
In this study, we only enrolled APA patients that underwent adrenalectomy, but not patients with 
bilateral adrenal hyperplasia. Adrenalectomy is the treatment of choice for APA patients. In contrast, 
medical treatment with spironolactone is the treatment of choice in patients with bilateral adrenal hyper-
plasia. Compared to medical treatment with spironolactone, adrenalectomy decreases left ventricular 
mass more quickly31. In another study, only adrenalectomy but not spironolactone improved arterial 
stiffness in PA patients (average follow-up period: one year)32. This evidence implies that adrenalectomy 
is a more effective method to reverse the effects of aldosterone on cardiovascular system. Therefore, 
Figure 1. The entropy over different time scales. a) The square open symbols represented the entropy of 
patients with EH, and the black solid dots the entropy of APA patients before surgery. b) The black solid 
dots represented the entropy of APA patients before surgery, and the open circles the entropy of APA 
patients after surgery. *p < 0.05.
DFAα2 Area 1–5 Area 6–15 Area 6–20
Age, years 0.038 − 0.048 − 0.053 − 0.065
Male sex − 0.148 0.044 0.110 0.110
History of hypertension, years − 0.086 0.079 0.091 0.067
Number of hypertensive 
medication 0.272 − 0.052 − 0.047 − 0.041
Body height, cm 0.162 0.014 − 0.090 − 0.083
Body weight, kg − 0.128 0.002 0.217 0.208
Log PAC 0.098 − 0.190 − 0.117 − 0.104
Log PRA − 0.177 0.402* 0.395* 0.379*
Log ARR 0.186 − 0.416* − 0.393* − 0.376*
Potassium, mmol/L − 0.101 0.181 0.356 # 0.355 #
SBP, mmHg − 0.103 − 0.308 − 0.014 − 0.012
DBP, mmHg − 0.089 − 0.015 − 0.015 − 0.024
LVMI, g/m2 0.000 − 0.263 − 0.200 − 0.212
LVEF, % − 0.111 0.087 − 0.037 − 0.049
Table 3.  Correlation between clinical parameters and non-linear Holter parameters (n = 45). Values 
are correlation coefficients. PAC = plasma aldosterone concentration; PRA = plasma renin activity; 
ARR = aldosterone-renin ratio; SBP = systolic blood pressure; DBP = diastolic blood pressure; *p < = 0.01; 
#p < 0.05.
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we enrolled APA patients that underwent adrenalectomy as the study group to enhance the difference 
between pre- and post-treatment.
One advantage of this study is that the BP and the number of antihypertensive medications was com-
parable between APA and EH groups. It is common that PA patients have significantly higher BP than 
EH patients33. In our previous studies, APA patients also had significantly higher BP than EH patients4,5. 






 SBP, mmHg 148 ± 13 144 ± 16 0.416
 DBP, mmHg 92 ± 11 90 ± 12 0.401
 Number of 
hypertensive medication 1.8 ± 1.1 0.7 ± 0.8 < 0.001
Biochemical parameters
 Potassium, mmol/L 3.3 ± 0.8 4.3 ± 0.5 < 0.001
 Log PAC 1.6 ± 0.3 1.5 ± 0.2 0.032
 Log PRA − 0.9 ± 0.9 − 0.1 ± 0.7 0.003
 Log ARR 2.6 ± 0.9 1.5 ± 0.7 0.002
Echocardiographic parameters
 LVMI, g/m2 135 ± 38 113 ± 24 0.004
 LVEF, % 71 ± 7 70 ± 9 0.569
Table 4.  Clinical parameters before and one year after adrenalectomy (n = 20). Values are mean ± SD. 
SBP = systolic blood pressure; DBP = diastolic blood pressure; PAC = plasma aldosterone concentration; 







 Mean, mm 750 ± 102 706 ± 119 0.075
 SDNN, mm 72 ± 18 70 ± 19 0.798
 pNN20, mm 20 ± 16 16 ± 14 0.208
 pNN50, mm 2.8 ± 4.0 2.8 ± 4.0 0.473
Frequency domain analysis
 High frequency 107 ± 115 98 ± 120 0.740
 Low frequency 263 ± 154 352 ± 357 0.243
 LF/HF ratio 4.0 ± 2.3 5.1 ± 3.5 0.188
 Very low frequency 968 ± 376 829 ± 373 0.122
Detrended fluctuation analysis
 α 1 1.29 ± 0.19 1.37 ± 0.17 0.169
 α 2 1.19 ± 0.09 1.13 ± 0.13 0.043
Multiscale entropy
 Area 1–5 5.4 ± 1.3 6.3 ± 1.1 0.007
 Slope 5 0.067 ± 0.055 0.098 ± 0.051 0.035
 Area 6–15 13.4 ± 2.4 15.5 ± 1.8 0.001
 Area 6–20 20.4 ± 3.6 23.4 ± 2.7 0.003
Table 5.  Holter parameters before and one year after adrenalectomy (n = 20). Values are mean ± SD. 
Values are mean ± SD. APA = aldosterone producing adenoma; EH = essential hypertension; 
SDNN = standard deviation of normal RR intervals; pNN20 = percentage of absolute differences in normal 
RR intervals greater than 20 ms; pNN50 = percentage of absolute differences in normal RR intervals greater 
than 50 ms; LF/HF = low frequency to high frequency.
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in this study) would make the interpretation of results more difficult and complex. Although the cor-
relations between HRV parameters and BP were not significant, we still could not exclude a possible 
confounding effect from a difference in BP. Thankfully, the BP difference was not significant between 
APA and EH groups in this study, which made the interpretation easier.
Our study has several limitations. First, the study population is small. Further large prospective stud-
ies are needed to confirm the results. Second, we did not measure muscle SNA to evaluate sympathetic 
activity. However, the main purpose of this study was to evaluate the influence of aldosterone on heart 
rhythm complexity rather than sympathetic activity per se.
In conclusion, APA patients had impaired heart rhythm complexity compared to EH patients, and this 
was independent of BP. The impaired heart rhythm complexity improved after adrenalectomy.
Methods
Patients. This prospective study enrolled 20 patients diagnosed with unilateral APA and who under-
went adrenalectomy during the period from December 2006 to October 2009. The patients were evalu-
ated and registered in the Taiwan Primary Aldosteronism Investigation (TAIPAI) database. The database 
was constructed for quality assurance in two medical centers (National Taiwan University Hospital 
(NTUH), Taipei; Taipei Medical University Hospital, Taipei), three metropolitan hospitals (Cardinal Tien 
Hospital, New Taipei City; Taipei Tzu Chi Hospital, New Taipei City; Yun-Lin Branch of NTUH, Douliou 
City), and two local hospitals (Hsin-Chu Branch of NTUH, Hsin-Chu City; Zhongxing Branch of Taipei 
City Hospital, Taipei)34–36. In addition, another 25 patients with EH were enrolled as the control group. 
Medical history including demography and medication was carefully recorded. Biochemical parameters 
were measured at the first evaluation of these patients in National Taiwan University Hospital. PRA was 
measured as the generation of angiotensin-I in vitro using a commercially available radioimmunoassay 
kit (Cisbio, Bedford, MA); PAC was measured by radioimmunoassay with commercial kits (Aldosterone 
Maia Kit; Adaltis Italia, Bologna, Italy). All antihypertensive medications were discontinued for at least 
21 days before measuring plasma PRA and PAC levels. Diltiazem and/or doxazosin were administered 
for control of marked high blood pressure when required. All APA patients underwent 24-h ambulatory 
ECG Holter recording (MyECG E3-80, Mircostar Company, Taipei) within 3 months before operation 
and one year after operation. EH patients also underwent 24-h ambulatory ECG Holter recording at the 
time of enrollment. The ECG signals were sampled at 250 Hz and stored in secure digital memory card 
for offline analysis on a microcomputer. This study was approved by the Institutional Review Board of 
National Taiwan University Hospital, and all subjects gave informed consent in written form including 
for the storage of their information in the hospital database and usage for research. The methods in the 
study were carried out in accordance with the approved guidelines.
Data Pre-Processing. Each digitalized 24-hour ECG data was annotated by an automatic algorithm 
then carefully inspected and corrected by the technicians for extracting the RR intervals and the ectopic 
beats were interpolated by its adjacent RR intervals. A four-hour length of RR intervals within daytime 
(between 9 AM–5 PM) was selected for analysis in order to avoid the confounding effects that may occur 
due to sleep or diurnal rhythm37. Only the RR series of subjects in whom qualified normal sinus beats 
made up more than 80% of the recording were included for further analysis.
Time and frequency domain analysis. The standard deviation of normal RR intervals, the per-
centage of the absolute change in consecutive normal RR interval exceeds 50 ms, and percentage of the 
absolute change in consecutive normal RR interval exceeds 20 ms were calculated to represent the total 
variance and vagal modulation of heart rate. The spectrum analyses were carried out according to the 
recommendations from the European Society of Cardiology and the North American Society of Pacing 
Electrophysiology10. Instead of calculating the spectrum in overall length, we divided the data into 16 
segments and Fourier transformation was performed individually to avoid the influence of external non-
stationarity. The spectral density of each frequency band- high frequency (0.15–0.4 Hz), low frequency 
(0.04–0.15 Hz), and very low frequency (0.003–0.04 Hz) were computed by averaging the absolute powers 
(msec2) in separated segments.
Nonlinear methods. Nonlinear analysis enables researchers to probe the fundamental characteristics 
of the signals. We apply two methods (DFA and MSE) for their ability to evaluate the underling proper-
ties of the signals hidden beneath the seemingly chaotic dynamics20,38.
DFA analysis. DFA is a modified root-mean-square analysis that is used to evaluate the fractal corre-
lation (a time-invariant property) beneath the heart rate fluctuation originated from the well-interacted 
regulatory mechanisms38. First, it eliminates the environmental inferences by removing the linear-fitted 
“local” trend over different time scales in an integrated time series. Then, the root-mean-square fluctua-
tion of this integrated and detrended time series is calculated. This procedure is repeated in different time 
scales and then the slope of the curve (α exponent) can be computed on the log-log plot of fluctuation 
versus box size which indicates the fractal correlation property of the time series.
Since the heart rate oscillation over short timescale is predominated by respiratory sinus arrhythmia, 
a crossover phenomenon of the α exponent in heart rate dynamics between short (4–11 beats) and long 
www.nature.com/scientificreports/
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(11–64 beats) time scales has been proposed to provide better understanding of the fractal correlation 
property in a physiological system38. The short-term (α 1) as well as long-term (α 2) fractal correlation 
were calculated.
MSE analysis. In contrast to simply using a single time scale to estimate the predictability of a time 
series, MSE assesses the complex structure of the physiological signals in different time scales. It com-
prises two steps: 1) coarse-graining the signals into different time scales; 2) quantifying the degree of 
predictability in each coarse-grained time series by using sample entropy39. The calculated entropy can 
be represented as a function of scale provides the meaningful information richness embedded in dif-
ferent time scales. It has been shown that different features of small and large scales in different groups 
of subjects may assist the clinical categorization20. Therefore, four different parameters were calculated 
from the MSE profile: the summations of entropy values of scale 1–5 (area 1–5), scale 6–15 (area 6–15), 
or scale 6–20 (area 6–20) which quantify the complexity exhibited in short and long time scales, respec-
tively; and the linear-fitted slope of scale 1–5 (slope 5) was also calculated to characterize the behavior 
of short-scale (Fig. 2)20.
In order to avoid an unwanted effect of external nonstationarity which may compromise the 
entropy-based analysis, we use the empirical mode decomposition method which is based on 
Hilbert-Huang transform to detrend the original R-R interval signals40. The data was subsequently eval-
uated by the MSE analysis after processing. Instead of removing trend with a priori mathematical for-
mulas such as polynomial or linear functions, the empirical mode decomposition algorithm could better 
approximate the hidden trend in complex time series40–42.
Diagnosis of APA. APA was diagnosed on the basis on the following four conditions: (1) autonomous 
excess aldosterone production evidenced with an ARR > 35, a TAIPAI score larger than 60%43, and 
post-saline loading PAC > 10 ng/dl; (2) adenoma evidenced with a computed tomography (CT) scan on 
pre-operative evaluation; (3) lateralization of aldosterone secretion at adrenal venous sampling or during 
dexamethasone suppression NP-59 SPECT/CT44; (4) pathologically proven adenoma after adrenalec-
tomy for those undergoing surgery, and subsequent cure or improvement of hypertension control with 
correction of hypokalemia and normalization of PAC and PRA34,45. Dexamethasone suppression NP-59 
SPECT/CT was used in patients who were at risk of contrast nephropathy, had inconclusive results from 
adrenal venous sampling or had discordant lateralization between imaging studies (such as CT) and 
adrenal venous sampling.
Echocardiography. A Hewlett-Packard Sonos 5500 ultrasound system equipped with a S3 transducer 
was used. Echocardiography including two-dimensional, M-mode and Doppler ultrasound recordings 
were performed. Left ventricular dimension, interventricular septum and posterior wall thicknesses, and 
left ventricular ejection fraction (M-mode) were measured via a parasternal long axis view. Left ventricu-
lar mass index was calculated according to the method of Devereux et al.46.
Figure 2. Quantification of MSE: The summation of the entropy over different scales can quantify the 
complexity over certain time scales. Four parameters of the MSE were assessed. The first two of these 
were the linear-fitted slope between scales 1–5 (slope 5); the area under curve between scale 1–5 (area 1–5) 
to represent complexity between short scales. For longer scales, the common profile of entropy gradually 
increases as the time scale elongates and reaches a plateau around scale 15 where information richness can 
be accumulated rapidly if the system can respond well. We therefore calculated both the area under curve 
between scales 6–15 (area 6–15) and 6–20 (area 6–20) to represent complexity between long scales.
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Post-adrenalectomy follow-up. Repeat serum biochemistry, PAC, PRA, 24-h ambulatory ECG 
Holter recording and echocardiography were performed one year after adrenalectomy. Hypertension 
was considered cured if the blood pressure decreased to 140/90 mm Hg or less after adrenalectomy, and 
anti-hypertensive medications were not required. These criteria had to be met one year post adrenalec-
tomy31. Patients who were cured within one year but later developed hypertension were still classified 
as cured.
Statistical analysis. Data were expressed as mean ± SD. Comparisons for continuous data between 
APA and EH patients were made using the t test. Differences between proportions were assessed by 
chi-square or Fisher exact test. Comparisons between pre-operative and post-operative parameters were 
made using paired t test. The Pearson’s correlation test was used to analyze the association among heart 
rhythm complexity parameters and its determinants. Data of PAC, PRA, and ARR were log-transformed 
before the correlation study due to non-normality which was determined by the Kolmogorov-Smirnov 
test. Before further analysis, the log-transformed data were tested again to assure the normality of dis-
tribution. Significant determinants in the Pearson’s correlation test (p < 0.05) were then tested by a mul-
tivariate linear regression test with stepwise subset selection to identify independent factors to predict 
MSE parameters. A value of p < 0.05 was considered to indicate statistical significance.
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